Home > Back to Publisher > Report Information

The Global Anti-Addiction Market, 2008-2023

Visiongain
November 5, 2008
138 Pages - SKU: VSG2022269

Abstract Table of Contents Related Reports

Countries covered: Global

The Global Anti-Addiction Market, 2008-2023

The global addiction market is significantly undervalued. The world’s population has a large unmet need for addiction therapy drugs. Are you ready for the opportunities this presents? The brand new report, The Global Anti-Addiction Market, 2008-2023, provides an in-depth analysis of the current state of the market for addiction therapy drugs, from the present looking forward. It covers the major therapy areas of smoking cessation, obesity, drug addiction and alcohol dependency. In addition, this study forecasts how your market will grow and develop, both quantitatively and qualitatively, during the period 2008-2023.

The Global Anti-Addiction Market, 2008-2023, uses a variety of primary and secondary research methods, including:

Exclusive visiongain interviews with key opinion leaders in the addiction industry
Examination of a wealth of secondary sources, including company reports, filings, analyst presentations and press releases
Use of in-house and commercial sales databases.

Addiction rates are increasing, yet there is a relative lack of widely-efficacious drugs. Also, relatively few patients are treated and patient compliance is low for those who are treated at present. Nevertheless, the growth potential market of this market is significant, both in developed and developing countries. In addition, awareness of the human and healthcare costs associated with addiction is increasing amongst patients, healthcare practitioners and legislators. There is a sense of urgency to combat tobacco addiction, alcoholism and obesity in particular. Consequently, there are marked opportunities for companies marketing and developing anti-addiction drugs. But by how much will the market grow and which therapy areas will be the fastest growing? This report answers those questions and more besides.

Visiongain has applied detailed financial forecasting and analysis of market/industry drivers and restraints, including SWOT analysis. The resulting comprehensive market-based report reveals how leading addiction brands, therapy areas and markets will fare during the period 2008 to 2023. Key features of the addiction drugs of the future and the hurdles they will have to overcome for commercial success are discussed.

Other highlights of The Global Anti-Addiction Market, 2008-2023 report include:

Expert opinion from representatives in the anti-addiction drug industry
Sales forecasts for the global addiction market and for individual obesity, smoking cessation, drug addiction and alcohol addiction markets, including leading brands, manufacturers and country markets
Examination of strengths, weakness, opportunities and threats (SWOT) facing major stakeholders in the anti-addiction drugs market
In-depth analysis of the anti-addiction pipeline
Geographical breakdown of the anti-addiction drugs market
Analysis of the addiction markets in the US, France and the UK.

Why you should buy this report:

To receive a comprehensive analysis of the prospects for anti-addiction drugs, including key metrics and predicted revenues, by type of addiction and brand
To receive forecasts of addiction drug sales, from 2008-2023, in leading country markets, including China and Mexico
To read the views of experts in the addiction industry, regarding current and future trends, opportunities and sales drivers; the report includes full transcripts of interviews
The report is packed with graphs, charts, figure and tables of analysis and sales forecasts
To determine the forces that influence the market for anti-addiction drugs: drivers, restraints, opportunities and competitive factors
To find out where the addiction market is heading - both technologically and commercially from 2008 onwards.

The information contained in this report is not available in any other source and is essential reading for you and your colleagues. By ordering and reading this report you can gain market advantage on your competitors today. When aligned with your in-house findings we are confident you will continue to succeed over the next 15 years.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

1 Executive Summary
2 Introduction: Worldwide Prevalence and Treatment of Addiction: 2.1 The Physiology and Psychology of Addiction; 2.2 Prevalence of Addiction; 2.3 Addiction Therapy; 2.4 Smoking Cessation Products; 2.5 Obesity Drugs; 2.6 Drugs Used In Opioid Dependence; 2.7 Alcohol Dependency Drugs
3 The Global Addiction Market: 3.1 The Addiction Market in 2007; 3.2 Global Addiction Market Forecasts, 2008-2023
4 The Global Smoking Cessation Market: 4.1 The Smoking Cessation Market in 2007; 4.2 Smoking Cessation Market Forecasts, 2008-2023
5 The Global Obesity Market: 5.1 The Obesity Market in 2007; 5.2 Obesity Market Forecasts, 2008-2023
6 The Global Drug Addiction Market: 6.1 The Drug Addiction Market in 2007; 6.2 Drug Addiction Market Forecasts, 2008-2023
7 The Global Alcohol Dependency Market: 7.1 The Alcohol Dependency Market in 2007; 7.2 Alcohol Dependency Market Forecasts, 2008-2023
8 Leading Addiction Country Markets: 8.1 Top Twelve Addiction Country Markets, 2007; 8.2 Addiction Market Country Forecasts, 2008-2023; 8.3 The US Addiction Market; 8.4 The UK Addiction Market; 8.5 The French Addiction Market
9 SWOT Analysis of the Addiction Market: 9.1 Analysis of the Market; 9.2 Strengths of the Addiction Industry; 9.3 Weaknesses of the Addiction Therapy Industry; 9.4 Opportunities in the Addiction Market; 9.5 Threats to the Addiction Market
10 The Addiction Therapy Pipeline: 10.1 Some Areas of the Addiction Pipeline are Stronger than Others; 10.2 The Smoking Cessation Product Pipeline; 10.3 The Obesity Drug Pipeline; 10.5 The Alcohol Dependency Therapy Pipeline; 10.6 The Pipeline for Other Addiction Therapies
11 Expert Opinion from Key Opinion-Leaders in the Addiction Industry: 11.1 Dr Raafat Fahim, President and Chief Executive Officer, Nabi Biopharmaceuticals; 11.2 Industry Representative from the Addiction Therapy Sector
12 Conclusions: 12.1 The Addiction Market in 2007; 12.2 Opportunity for Growth in the Addiction Market; 12.3 Visiongain's Forecast for the Addiction Market, 2008-2023
List of Tables: Table 2.1 Global Prevalence of Addiction and Drug Use; Table 2.2 Key Drugs Prescribed Off-Label for Addiction Therapy; Table 2.3 Major Johnson & Johnson Nicotine Replacement Therapy Brands; Table 2.4 Major GSK Nicotine Replacement Therapy Brands; Table 2.5 Major Novartis Nicotine Replacement Therapy Brands; Table 3.1 Leading Addiction Therapy Areas, 2007; Table 3.2 Leading Addiction Brands, 2007; Table 3.3 Leading Manufacturers of Addiction Drugs, 2007; Table 3.4 Global Addiction Market Forecast, 2008-2013; Table 3.5 Global Addiction Market Forecast, 2014-2023; Table 3.6 Addiction Therapy Area Sales Forecast, 2008-2013; Table 3.7 Addiction Therapy Area Sales Forecast, 2014-2023; Table 4.1 Leading Smoking Cessation Product Types, 2007; Table 4.2 Leading Manufacturers of Smoking Cessation Products, 2007; Table 4.3 Global Smoking Cessation Market Forecast, 2008-2013; Table 4.4 Global Smoking Cessation Market Forecast, 2014-2023; Table 4.5 Smoking Cessation Product Type Sales Forecast, 2008-2013; Table 4.6 Smoking Cessation Product Type Sales Forecast, 2014-2023; Table 5.1 Leading Obesity Brands, 2007; Table 5.2 Leading Manufacturers of Obesity Drugs, 2007; Table 5.3 Global Obesity Market Forecast, 2008-2013; Table 5.4 Global Obesity Market Forecast, 2014-2023; Table 5.5 Obesity Brands Sales Forecasts, 2008-2013; Table 5.6 Obesity Brands Sales Forecasts, 2014-2023; Table 6.1 Leading Drug Addiction Product Types, 2007; Table 6.2 Leading Manufacturers of Drug Addiction Products, 2007; Table 6.3 Global Drug Addiction Market Forecast, 2008-2013; Table 6.4 Global Drug Addiction Market Forecast, 2014-2023; Table 6.5 Drug Addiction Product Type Sales Forecast, 2008-2013; Table 6.6 Drug Addiction Product Type Sales Forecast, 2014-2023; Table 6.7 Suboxone/Subutex Sales Forecast, 2008-2013; Table 6.8 Suboxone/Subutex Sales Forecast, 2014-2023; Table 7.1 Leading Alcohol Dependency Drug Types, 2007; Table 7.2 Leading Manufacturers of Alcohol Dependency Drugs, 2007; Table 7.3 Global Alcohol Dependency Market Forecast, 2008-2013; Table 7.4 Global Alcohol Dependency Market Forecast, 2014-2023; Table 7.5 Alcohol Dependency Drug Type Sales Forecast, 2008-2013; Table 7.6 Alcohol Dependency Drug Type Sales Forecast, 2014-2023; Table 7.7 Campral/Aotal and Vivitrol Sales Forecast, 2008-2013; Table 7.8 Campral/Aotal and Vivitrol Sales Forecast, 2014-2023; Table 8.1 Top Twelve Addiction Country Markets, 2007; Table 8.2 Addiction Market Country Forecasts, 2008-2013; Table 8.3 Addiction Market Country Forecasts, 2014-2023; Table 8.4 Prevalence of Addiction and Drug Use in the US; Table 8.5 The US Addiction Market, 2007; Table 8.6 Prevalence of Addiction and Drug Use in the UK; Table 8.7 The UK Addiction Market, 2007; Table 8.8 Prevalence of Addiction and Drug Use in France; Table 8.9 The French Addiction Market, 2007; Table 9.1 SWOT Chart for Addiction Market; Table 9.2 Prevalence of Tobacco Use Worldwide and in Major Country Markets; Table 9.3 Prevalence of Obesity Worldwide and in Major Country Markets; Table 9.4 Worldwide Drug Use, 2006/07; Table 9.5 Prevalence of Opioid Drug Use Worldwide and in Major Country Markets; Table 9.6 Prevalence of Cocaine Use Worldwide and in Major Country; Table 9.7 Alcohol Consumption & Dependence Worldwide & in Major Country Markets; Table 10.1 Key Smoking Cessation Pipeline Products; Table 10.2 Key Obesity Pipeline Drugs; Table 10.3 Key Drug Addiction Pipeline Therapies; Table 10.4 Key Alcohol Dependency Pipeline Drugs
List of Figures: Figure 3.1 Leading Addiction Therapy Areas, 2007; Figure 3.2 Leading Addiction Brands, 2007; Figure 3.3 Leading Manufacturers of Addiction Drugs, 2007; Figure 3.4 Global Addiction Market Forecast, 2008-2023; Figure 3.5 Addiction Therapy Area Sales Forecast, 2008-2023; Figure 3.6 Addiction Therapy Area Sales Forecast and Market Share, 2008-2023; Figure 3.7 Addiction Therapy Area Market Share, 2013; Figure 3.8 Addiction Therapy Area Market Share, 2018; Figure 3.9 Addiction Therapy Area Market Share, 2023; Figure 4.1 Leading Smoking Cessation Product Types, 2007; Figure 4.2 Leading Manufacturers of Smoking Cessation Products, 2007; Figure 4.3 Global Smoking Cessation Market Forecast, 2008-2023; Figure 4.4 Smoking Cessation Product Type Sales Forecast, 2008-2023; Figure 4.5 Smoking Cessation Product Type Sales Forecast & Market Share, 2008-2023; Figure 4.6 Chantix/Champix Sales Forecast, 2008-2023; Figure 5.1 Leading Obesity Brands, 2007; Figure 5.2 Leading Manufacturers of Obesity Drugs, 2007; Figure 5.3 Global Obesity Market Forecast, 2008-2023; Figure 5.4 Xenical Sales Forecast, 2008-2023; Figure 5.5 Reductil/Meridia Sales Forecast, 2008-2023; Figure 5.6 Alli Sales Forecast, 2008-2023; Figure 5.7 Acomplia Sales Forecast, 2008-2023; Figure 6.1 Leading Drug Addiction Product Types, 2007; Figure 6.2 Leading Manufacturers of Drug Addiction Products, 2007; Figure 6.3 Global Drug Addiction Market Forecast, 2008-2023; Figure 6.4 Drug Addiction Product Type Sales Forecast, 2008-2023; Figure 6.5 Drug Addiction Product Type Sales Forecast and Market Share, 2008-2023; Figure 6.6 Suboxone/Subutex Sales Forecast, 2008-2023; Figure 7.1 Leading Alcohol Dependency Drug Types, 2007; Figure 7.2 Leading Manufacturers of Alcohol Dependency Drugs, 2007; Figure 7.3 Global Alcohol Dependency Market Forecast, 2008-2023; Figure 7.4 Alcohol Dependency Drug Type Sales Forecast, 2008-2023; Figure 7.5 Alcohol Dependency Drug Type Sales Forecast and Market Share, 2008-2023; Figure 7.6 Campral/Aotal Sales Forecast, 2008-2023; Figure 7.7 Vivitrol Sales Forecast, 2008-2023; Figure 8.1 Leading Addiction Country Markets, 2007; Figure 8.2 Leading Addiction Country Markets, 2013; Figure 8.3 Leading Addiction Country Markets, 2018; Figure 8.4 Leading Addiction Country Markets, 2023; Figure 8.5 The US Addiction Market, 2007; Figure 8.6 US Addiction Market Sales Forecast, 2008-2023; Figure 8.7 The UK Addiction Market, 2007; Figure 8.8 UK Addiction Market Sales Forecast, 2008-2023; Figure 8.9 The French Addiction Market, 2007; Figure 8.10 French Addiction Market Sales Forecast, 2008-2023; Figure 9.1 Top-Ten Countries for Numbers of Tobacco Users; Figure 9.2 Prevalence of Obesity in Major Country Markets; Figure 9.3 Prevalence of Opioid Drug Use in Major Country Markets; Figure 9.4 Prevalence of Cocaine Use in Major Country Markets; Figure 9.5 Alcohol Consumption and Dependence in Major Country Markets; Abbott Laboratories; Actavis; Alizyme; Alkermes; Amylin; Arena; AstraZeneca; Barr; Biotie Therapies (Finland); Biovail; Bristol-Myers Squibb; Celtic Pharma; Cephalon; CV Therapeutics; Cytos Biotechnology; Drake University (US); Eisai; Elbion NV; Eli Lilly; European Medicines Agency (EMEA); European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); Evotec; Food and Drug Administration (FDA); Forest; GSK; Independent Pharmaceutica; Indevus; Johnson & Johnson; Karolinska Institutet (Sweden); Lundbeck; Medley (Brazil); Merck & Co.; Merck KGaA; Nabi Biopharmaceuticals; National Health Service (NHS, UK); National Institute for Health and Clinical Excellence (NICE, UK); National Institute on Drug Abuse (NIDA, USA); National Institutes of Health (NIH, USA); Novartis; Novo Nordisk; OBEcure; Orexigen; Pfizer; Reckitt Benckiser; Roche; Rottapharm (Italy); Sanofi-Aventis; Schering-Plough; Solvay; Somaxon; Synosia Therapeutics; Takeda; Titan; Vivant; WEX Pharmaceuticals; World Health Organization (WHO); Xytis; Yaupon Therapeutics

More Global Smoking Cessation Reports

The World Market for Over The Counter (OTC) Drugs by Kalorama Information
Over-the-counter (OTC), non-legend, and non-prescription are all adjectives describing drugs that an individual may purchase without a prescription. Many pharmaceutical companies seeking more revenue and ...

World Smoking-Cessation Drug Market 2010-2025 by Visiongain
Smoking is a leading cause of preventable death worldwide. In 2009, total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute ...

Smoking Cessation: World Markets by Kalorama Information
Smoking cessation is among the most dynamic pharmaceutical markets, and one that is expected to grow despite economic conditions. More than 5 million deaths ...

Smoking Cessation Aids by Global Industry Analysts
This report analyzes the worldwide markets for Smoking Cessation Aids in US$ Million. The major product segments analyzed are Nicotine Gum, Nicotine Patch, Nicotine lozenges ...

Smoking Cessation and Addiction Treatments: A World Market Analysis by Kalorama Information
SMOKING CESSATION IS AN increasingly important area of focus for pharmaceutical companies, healthcare entities and governments. There are 1.4 billion smokers in the world, ...

See all reports like this >>

The Global Anti-Addiction Market, 2008-2023

Share this report

Other tasks

Research Assistance

Related Markets

Smoking Cessation Reports

Free Alert Me service